Novel approaches to brain disorder diagnosis and treatment may be developed following a project to form a map of the mouse hippocampus.
List view / Grid view
The scientists used a new in vitro platform, which allowed intestinal organoids to be cultured on an open lumen, planar system that could be manipulated experimentally.
Researchers have established a list of compounds that effect cytokine storms that could reduce mortality in COVID-19 patients.
Synthetic biology processes can be useful to therapeutic development, diagnostics and vaccine advancement. Drug Target Review’s Victoria Rees spoke with Dr Jim Collins, Termeer Professor of Medical Engineering & Science at MIT and Founding Core Faculty & Lead, Living Cellular Devices at the Wyss Institute at Harvard University, to explore…
New insights into lung squamous cell carcinoma (LSCC) have emerged from a proteogenomic study, leading to the identification of potential drug targets.
MIT researchers have shown that a combination of three drugs can eliminate pancreatic tumours in mice, possibly leading to new therapies.
Researchers have created a single-celled synthetic organism able to grow and divide that could be used to produce drugs and detect disease.
A novel machine learning method called DeepBAR could accelerate drug discovery and protein engineering, researchers say.
Researchers have shown antibodies induced by the Pfizer and Moderna vaccines are less effective at neutralising certain SARS-CoV-2 variants.
A team has developed a machine learning approach to screen for and identify drugs that could be repurposed against COVID-19 in the elderly.
Jim Shanahan from SynDevRx explains why metabo-oncology treatment modalities could be the answer to a rise in metabolic disorders and cancers.
A team has used their new organs-on-a-chip system to replicate the interactions between the brain, liver and colon.